ERIC ROSS: Open Payments
NPI 1629743901 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 10 payments from 7 companies in 2025. Trend: 2023 $374 · 2024 $40 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $56 |
| Novo Nordisk Inc | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Alkermes, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
Products named: QULIPTA, VIVITROL, TRELEGY ELLIPTA, ACCRUFER, ELIQUIS, Ozempic, MOUNJARO, Rybelsus.
Industry payments across PA — which companies pay providers there.
